Brevan Howard Capital Management’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
+56,155
New +$1.2M 0.01% 1039
2024
Q4
– Sell
-35,076
Closed -$792K – 1004
2024
Q3
$792K Buy
+35,076
New +$802K 0.01% 531
2024
Q2
– Sell
-11,007
Closed -$362K – 1027
2024
Q1
$362K Buy
+11,007
New +$375K ﹤0.01% 578
2023
Q4
– Sell
-10,934
Closed -$401K – 1011
2023
Q3
$401K Buy
+10,934
New +$436K 0.01% 199

Other funds holding ADNT

Brevan Howard Capital Management's ADNT Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Adient (ADNT) in Q2 2026: 56,155 shares worth $1.03M. The stake represents 0.01% of the portfolio and ranks #1039 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in ADNT as recently as Q3 2024.

Brevan Howard Capital Management first reported a position in ADNT in Q3 2023 and has held it in 4 quarters since. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Brevan Howard Capital Management held 56,155 shares of Adient worth $1.03M as of Q2 2026.
  • Adient was a new Brevan Howard Capital Management position in Q2 2026.
  • Adient made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1039 holding.
  • Brevan Howard Capital Management first reported a position in Adient in Q3 2023 and has held it in 4 quarters since.
  • 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.